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Although CDCA bioavailability has been measured using peripheral blood concentration time curves (van BergeHenegouwen & Hofmann, 1977, Gastroenterology, 73, 300-309; Ponz de Leon & Hermon Dowling, 1977, Gut, 18, In press ) the magnitude and timing of peak serum CDCA levels vary widely from subject to subject. The role played by such factors as gastric emptying and the pharmaceutical formulation of CDCA in the peripheral blood CDCA response is not known nor have studies of within subject variation been made.
We therefore compared 4 h serum CDCA concentrationtime curves (measured by RIA) in fasting control subjects given 250 mg oral CDCA, first as a capsule and later as an entericcoated tablet, and related results to corresponding 'tolerance curves' for two poorly-metabolizable sugars, 3-O-methylglucose and D-xylose given simultaneously as markers of gastric emptying and proximal intestinal absorption.
Gastric emptying was rapid as shown by first appearance of both sugars in peripheral blood 5-15 min after ingestion in all but one patient (40 min). Thereafter, serum 3-O-methylglucose and D-xylose levels rose quickly to reach maxima 15-50 min after initial appearance with little variation (5-15 min) between results for repeat studies in individual subjects--suggesting efficient and consistent absorption. By contrast, the rise in serum CDCA was later and the concentration-time curve more protracted with greater intra-and inter-individual variation than was seen with the marker sugars. There were no consistent differences in CDCA tolerance curves with different phar maceutical formulations.
Individual variability in CDCA bioavailability was unrelated to variable gastric emptying. Poor reproducibility and intersubject differences make comparative bioavailability studies difficult CDCA absorption was independent of the phar maceutical formulation used. The lysosomal granules of neutrophil leucocytes contain a potent elastase (Janoff & Scherer, 1968 , Journal ofExperimentalMedicine, 128,1137 , and it is thought that the release of this enzyme may bring about pulmonary emphysema in patients both with and without alpha,-antitrypsin deficiency. Lysosomal enzymes can be released from these cells during phagocytosis of inert material, and during pilot experiments we have shown that cigarette smoke can provoke such release. In the present study we have measured the latex-induced release of lysosomal enzymes from leucocytes of normal and emphysematous subjects and the modification of this release after additional treatment of the cells with the soluble components of cigarette smoke.
THE INDUCTION OF LYSOSOMAL ENZYME RELEASE FROM LEUCOCYTES OF NORMAL AND EMPHYSEMATOUS SUBJECTS AND THE EFFECTS
Thirty-two patients with radiological evidence of pulmonary emphysema were studied. Their mean age was 59 years (range 28-71). Their mean FEV, (±SD) as % of predicted was 37-5% (±20-0), vital capacity 79-3% (+20-9) and single breath CO transfer factor 48·2% (±28-2). Their mean arterial 0 2 tension was 8·6 kPa (+1-7). Seven healthy non-smoking subjects (mean age 34 + 6 years) were also studied. Fourteen were current cigarette smokers and the remaining 18 were ex-smokers. Only one of the patients was a female and two had α,-antitrypsin deficiency being homozygous for Pi type Z.
Leucocytes from each subject were isolated and incubated for 2 h with serum-treated latex particles, after which the acid phosphatase (AP), ribonuclease (RN) and lactate dehydrogenase (LDH) content of cells and supernatant medium were assayed. The quantity of lysosomal enzyme released was expressed as a percentage of the total cellular enzyme content (Table 1) . There was no significant difference in enzyme release between normal and emphysematous subjects. The same experiments were performed with the addition of cigarette smoke solution (filtered to remove paniculate matter) to the latex particles (Table 2 ). In the normal subjects there was a depression of enzyme release compared with latex used alone. This depression was not observed in the emphysematous subjects and the difference between the two groups of subjects was in this respect highly significant (P < 0-001). 
There was no significant difference between the relative amounts of AP and RN released in a given experiment. LDH release was minimal (<10% in all cases) and did not alter significantly upon addition of latex particles or smoke solution.
We have demonstrated in this study that lysosomal enzyme release from the leucocytes of both normal and emphysematous subjects is equally potentiated by the addition of a phagocytic stimulus, and the participate fraction of cigarette smoke may act in the same manner. The minimal cytoplasmic enzyme release indicates that the cells remain viable. In normal subjects, the observed inhibition of lysosomal enzyme release by the soluble fraction of cigarette smoke may be brought about by the presence of a factor such as carbon monoxide. Although the results showed no relationship to arterial 0 ; tension or smoking status, the leucocytes of emphysematous patients may have become adapted to hypoxic conditions so that inhibition of enzyme release does not occur.
BEDSIDE MEASUREMENT OF CARBON MONOX IDE DIFFUSING CAPACITY

